Related Stories
Progress
For Sopharma AD this effort is another contribution to an excellent corporate governance file.
Business & Markets
When financial information becomes an opportunity for futures analysts.
Corporate News
Financial News
14 September 2020
Online meeting with investors and exercising the right to vote by correspondence at the Extraordinary General Meetings of Shareholders convened on 25 September, 2020 from 11:00 and 11:30
Financial Highlights 30 June, 2020
678,997
BGN '000 Revenue
48,511
BGN '000 EBITDA
26,746
BGN '000 Revenue from operating profit
18,711
BGN '000 Net profit for the year
0.675
BGN Earnings per share
Next events
25 September 2020
Extraordinary General Meeting of Shareholders from 11:00 a.m. (UTC 8:00 a.m.) and publishing of the taken decisions.
25 September 2020
Extraordinary General Meeting of Shareholders from 11:30 a.m. (UTC 8:30 a.m.) and publishing of the taken decisions.
Equity story
85+ year track record in the pharma industry
-
Leadership -
Growth -
Portfolio -
Profitability -
Business Model -
M&A